Table 1 NeoSeq cohort characteristics
Gender, N (%) | |
|---|---|
Male | 43 (66) |
Female | 22 (34) |
Self-reported race/ethnicity, N (%) | |
American Indian or Alaska Native | 0 |
Asian | 1 (1.5) |
Black or African American | 1 (1.5) |
Caucasian | 39 (60) |
Latino(a) | 17 (26) |
Multiple | 6 (9) |
Asian-Caucasian mixed | 2 |
Latino-Caucasian mixed | 2 |
Native American-Caucasian mixed | 1 |
Native American-Latino mixed | 1 |
Native Hawaiian or Pacific Island | 1 (1.5) |
Group characteristics, N (%) | |
Gestational age | |
<32 weeks | 9 (14) |
32–37 weeks | 27 (41) |
>37 weeks | 29 (45) |
Birth weight | |
<2500 grams | 28 (43) |
>2500 grams | 37 (57) |
Identified prenatal period | 34 (52) |
Test ordering | |
Test ordered as | |
Trio | 60 (92) |
Duo (parent) | 2 (3) |
Duo (twin sibling) | 2 (3) |
Proband | 0 |
Quad (trio and sibling) | 1 (2) |
Time to testing | |
DOL test initiated | 8 days (0–71) |
Identification, discharge, mortality | |
Discharged home prior to ROR | 37 (57) |
Deceased prior to ROR | 6/18 (33) |
Deceased during hospitalization | 6/65 (9) |
Discharged to Level IV NICU | 23/65 (35) |
Length of Hospital Stay | 20.8 days (0–114 days) |
